Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by sollmgon Dec 04, 2020 1:44pm
171 Views
Post# 32038343

RE:RE:RE:It may have bottomed.

RE:RE:RE:It may have bottomed.
sollmg wrote: In addition Thomvest and Armistice are selling 14+ Million shares at $4.05 US. They keep the cash

https://www.sec.gov/Archives/edgar/data/1351172/000095012320012434/lmnl-f3.htm



8.4 mil of the shares will come from prefunded warrants. Exercise price .001. The way I read this is as an invitation to the hedge funds to short 14+ mil shares at $4.5 US (current price) and we will cover you at $4.05US. A nice 7+ million dollar profit at zero risk
<< Previous
Bullboard Posts
Next >>